Effect of a phytopharmaceutical medicine, Ginko biloba extract 761, in an animal model of Parkinson's disease: Therapeutic perspectives

Droy-Lefaix, 1995, Antioxidant effect of a Ginkgo biloba extract (EGb761) on the retina, Int J Tissue React, 17, 93 Maitra, 1995, Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761, Biochem Pharmacol, 49, 1649, 10.1016/0006-2952(95)00089-I Ni, 1996, Preventive effect of Ginkgo biloba extract on apoptosis in rat cerebellar neuronal cells induced by hydroxyl radicals, Neurosci Lett, 214, 115, 10.1016/0304-3940(96)12897-4 Rojas, 2008, EGb 761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress, Eur J Neurosci, 28, 41, 10.1111/j.1460-9568.2008.06314.x DeFeudis, 2000, Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications, Curr Drug Targets, 1, 25, 10.2174/1389450003349380 Gerlach, 1994, Altered brain metabolism of iron as a cause of neurodegenerative diseases?, J Neurochem, 63, 793, 10.1046/j.1471-4159.1994.63030793.x Jenner, 1996, Oxidative stress and the pathogenesis of Parkinson's disease, Neurology, 47, S161, 10.1212/WNL.47.6_Suppl_3.161S Dexter, 1994, Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study, Mov Disord, 9, 92, 10.1002/mds.870090115 Zhang, 1999, Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons, Am J Pathol, 154, 1423, 10.1016/S0002-9440(10)65396-5 Yao, 2009, Cell death pathways in Parkinson's disease: role of mitochondria, Antioxid Redox Signal, 11, 2135, 10.1089/ars.2009.2624 Perier, 2012, Mitochondria and programmed cell death in Parkinson's disease: apoptosis and beyond, Antioxid Redox Signal, 16, 883, 10.1089/ars.2011.4074 DeFeudis, 1998 Drieu, 1986, Preparation and definition of G. biloba extract, Press Med, 15, 1455 Kleijnen, 1992, Ginkgo biloba, Lancet, 340, 1136, 10.1016/0140-6736(92)93158-J Bilia, 2002, Ginkgo biloba L, Fitoterapia, 73, 276, 10.1016/S0367-326X(02)00071-0 Diamond, 2000, Ginkgo biloba extract: mechanisms and clinical indications, Arch Phys Med Rehabil, 81, 668 Rojas, 2001, EGb 761 blocks MPP+-induced lipid peroxidation in mouse corpus striatum, Neurochem Res, 26, 1245, 10.1023/A:1013971524150 Ernst, 2002, The risk–benefit profile of commonly used herbal therapies: Ginkgo, St John's wort, ginseng, Echinacea, saw palmetto and kawa, Ann Intern Med, 136, 42, 10.7326/0003-4819-136-1-200201010-00010 Tansey, 2010, Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention, Neurobiol Dis, 37, 510, 10.1016/j.nbd.2009.11.004 Chan, 2007, Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson's disease, CNS Neurol Disord Drug Targets, 6, 273, 10.2174/187152707781387288 Hynes, 1991, Leukotrienes in brain: natural occurrence and induced changes, Brain Res, 553, 4, 10.1016/0006-8993(91)90222-H Kunievsky, 1992, Platelet-activating factor stimulates arachidonic acid release and enhances thromboxane B2 production in intact fetal rat brain ex vivo, J Pharmacol Exp Ther, 263, 562 Shi, 2009, Dosage effects of EGb761 on hydrogen peroxide-induced cell death in SH-Sy5Y cells, Chem Biol Interact, 180, 389, 10.1016/j.cbi.2009.04.008 Du, 1998, Effects of ginkgolides on interleukin-1, tumor necrosis factor-alpha and nitric oxide production by rat microglia stimulated with lipopolysaccharides in vitro, Arzneim Forsch, 48, 1126 Marcocci, 1994, Antioxidant action of Ginkgo biloba extract EGb 761, Methods Enzymol, 234, 462, 10.1016/0076-6879(94)34117-6 Gardés-Albert, 1993, Oxygen-centered free radicals and their interactions with EGb 761 or CP 202, 1 Saija, 1995, Flavonoids as antioxidant agents: importance of their interaction with biomembranes, Free Radic Biol Med, 19, 481, 10.1016/0891-5849(94)00240-K Shi, 2009, Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against beta-amyloid peptide-induced toxicity in SH-SY5Y cells, Chem Biol Interact, 181, 115, 10.1016/j.cbi.2009.05.010 Sastre, 1998, A Ginkgo biloba extract (EGb 761) prevents mitochondrial aging by protecting against oxidative stress, Free Radic Biol Med, 24, 298, 10.1016/S0891-5849(97)00228-1 Bridi, 2001, The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats, Phytother Res, 15, 449, 10.1002/ptr.814 Pardon, 2000, In vivo regulation of cerebral monoamine oxidase activity in senescent controls and chronically stressed mice by long-term treatment with Ginkgo biloba extract (EGb 761), Mech Ageing Dev, 113, 157, 10.1016/S0047-6374(99)00107-4 Eckert, 2003, Effects of EGb 761 Ginkgo biloba extract on mitochondrial function and oxidative stress, Pharmacopsychiatry, 36, S15, 10.1055/s-2003-40449 Winter, 1998, The effects of an extract of Ginkgo biloba, 761, on cognitive behavior on longevity in the rat, Physyiol Behav, 63, 425, 10.1016/S0031-9384(97)00464-2 Liu, 2008, Ginkgo biloba extract 761 reduced doxorubicin-induced apoptotic damage in rat hearts and neonatal cardiomyocytes, Cardiovasc Res, 80, 227, 10.1093/cvr/cvn192 Yeh, 2009, A standardized extract of Ginkgo biloba suppresses doxorubicin-induced oxidative stress and p53-mediated mitochondrial apoptosis in rat testes, Br J Pharmacol, 156, 48, 10.1111/j.1476-5381.2008.00042.x Nevado, 2010, Ginkgo biloba extract (EGb 761) protects against aging-related caspase-mediated apoptosis in rat cochlea, Acta Otolaryngol, 130, 1101, 10.3109/00016481003713657 Lu, 2006, Molecular evidence of the neuroprotective effect of Ginkgo biloba (EGb 761) using bax/bcl-2 ratio after brain ischemia in senescence-accelerated mice, strain prone-8, Brain Res, 1090, 23, 10.1016/j.brainres.2006.02.138 Koh, 2009, Gingko biloba extract (EGb 761) prevents increase of bad-bcl_XL interaction following cerebral ischemia, Am J Chin Med, 37, 867, 10.1142/S0192415X0900734X Li, 2011, Biphasic effect of EGb 761 on simulated ischemia-induced rat BMSC survival in vitro and in vivo, Life Sci, 88, 853, 10.1016/j.lfs.2011.03.002 Lim, 2011, EGb761, a Ginkgo biloba extract, is effective against atherosclerosis in votro, and in a rat model of type 2 diabetes, PloS ONE, 6, 1, 10.1371/journal.pone.0020301 Wang, 2011, Protective effects of Ginkgo biloba extract on 6-hydroxydopamine-induced apoptosis in PC12 cells, Neural Regeneration Res, 6, 2565 Kang, 2007, Protective effects of Ginkgo biloba extract on paraquat-induced apoptosis of PC12 cells, Toxicol In Vitro, 21, 1003, 10.1016/j.tiv.2007.02.004 Yang, 2001, Protective effect and mechanism of Ginkgo biloba leaf extracts for Parkinson disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Acta Pharmacol Sin, 22, 1089 Tsang, 2009, Oxidative and nitrosative stress in Parkinson's disease, Biochim Biophys Acta, 1792, 643, 10.1016/j.bbadis.2008.12.006 Halliwell, 2011, Free radicals and antioxidants—quo vadis?, Trends Pharmacol Sci, 32, 125, 10.1016/j.tips.2010.12.002 Danielson, 2008, Oxidative and nitrative protein modifications in Parkinson's disease, Free Radic Biol Med, 44, 1787, 10.1016/j.freeradbiomed.2008.03.005 Andersen, 2004, Oxidative stress in neurodegeneration: cause or consequence?, Nat Med, 10, S18, 10.1038/nrn1434 Lenaz, 2002, Role of mitochondria in oxidative stress and aging, Ann N Y Acad Sci, 959, 199, 10.1111/j.1749-6632.2002.tb02094.x McLennan, 2000, The contribution of mitochondrial respiratory complexes to the production of reactive oxygen species, J Bioenerg Biomembr, 32, 153, 10.1023/A:1005507913372 Sayre, 2008, Oxidative stress and neurotoxicity, Chem Res Toxicol, 21, 172, 10.1021/tx700210j Hussain, 1995, Age related changes in antioxidant enzymes, superoxide dismutase, catalase, glutathione peroxidase and glutathione in different regions of mouse brain, Int J Dev Neurosci, 13, 811, 10.1016/0736-5748(95)00071-2 Dexter, 1989, Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease, J Neurochem, 52, 381, 10.1111/j.1471-4159.1989.tb09133.x Yoritaka, 1996, Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease, Proc Natl Acad Sci U S A, 93, 2696, 10.1073/pnas.93.7.2696 Floor, 1998, Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay, J Neurochem, 70, 268, 10.1046/j.1471-4159.1998.70010268.x Nakabeppu, 2007, Oxidative damage in nucleic acids and Parkinson's disease, J Neurosci Res, 85, 919, 10.1002/jnr.21191 Bender, 2006, High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease, Nat Gene, 38, 515, 10.1038/ng1769 Saggu, 1989, A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra, J Neurochem, 53, 692, 10.1111/j.1471-4159.1989.tb11759.x Amnabi, 1975, Brain peroxidase and catalase in Parkinson's disease, Arch Neurol, 32, 114, 10.1001/archneur.1975.00490440064010 Cohen, 1986, Monoamine oxidase, hydrogen peroxide, and Parkinson's disease, 119 Riederer, 1983, Neurochemical insights into monoamine oxidase inhibitors, with special reference to deprenyl (selegiline), Acta Neurol Scand Suppl, 95, 43, 10.1111/j.1600-0404.1983.tb01516.x Knoll, 1995, Rationale for (−) deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changes, Biomed Pharmacother, 49, 187, 10.1016/0753-3322(96)82619-9 Schapira, 2011, Etiology and pathogenesis of Parkinson's disease, Mov Disord, 26, 1049, 10.1002/mds.23732 Lipski, 2011, L-DOPA: a scapegoat for accelerated neurodegeneration in Parkinson's disease?, Prog Neurobiol, 94, 389, 10.1016/j.pneurobio.2011.06.005 Müller, 2011, Motor complications, levodopa metabolism and progression of Parkinson's disease, Expert Opin Drug Metab Toxicol, 7, 847, 10.1517/17425255.2011.575779 Gerlach, 1991, MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease, Eur J Pharmacol Mol Pharmacol, 208, 273, 10.1016/0922-4106(91)90073-Q Przedborski, 2000, The parkinsonian toxin MPTP: action and mechanism, Restor Neurol Neurosci, 16, 135 Zang, 1993, Generation of reactive oxygen species during the monoamine oxidase-catalyzed oxidation of the neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, J Biol Chem, 268, 16504, 10.1016/S0021-9258(19)85448-0 Adams, 1993, MPP+ and MPDP+ induced oxygen radical formation with mitochondrial enzymes, Free Radic Biol Med, 15, 181, 10.1016/0891-5849(93)90057-2 Wong, 1999, Oxidative stress induced by MPTP and MPP(+): selective vulnerability of cultured mouse astrocytes, Brain Res, 836, 237, 10.1016/S0006-8993(99)01661-3 Yurek, 1989, Morphological, neurochemical, and behavioral characterizations associated with the combined treatment of diethyldithiocarbamate and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice, Brain Res, 497, 250, 10.1016/0006-8993(89)90270-9 Przedborski, 1992, Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity, J Neurosci, 12, 1658, 10.1523/JNEUROSCI.12-05-01658.1992 Rojas, 1993, Increased striatal lipid peroxidation after intracerebroventricular MPP+ administration to mice, Pharmacol Toxicol, 72, 364, 10.1111/j.1600-0773.1993.tb01345.x Park, 2004, Preventive effect of antioxidants in MPTP-induced mouse model of Parkinson's disease, Neurosci Lett, 363, 243, 10.1016/j.neulet.2004.03.072 Ramassamy, 1993, Ginkgo biloba extract EGb 761 or trolox C prevent the ascorbic ac id/Fe 2+ induced decrease in synaptosomal membrane fluidity, Free Radic Res Commun, 19, 341, 10.3109/10715769309056523 Ahmad, 2005, Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine–induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences, J Neurochem, 93, 94, 10.1111/j.1471-4159.2005.03000.x Kang, 2007, Protective effects of Ginkgo biloba extract on paraquat-induced apoptosis of PC12 cells, Toxicol In Vitro, 21, 1003, 10.1016/j.tiv.2007.02.004 Kim, 2004, Neuroprotective effect of Ginkgo biloba L. extract in a rat model of Parkinson's disease, Phytother Res, 18, 663, 10.1002/ptr.1486 Rafalowska, 1989, Peroxidation induced changes in synaptosomal transport of dopamine and gamma-aminobutyric acid, Free Radic Biol Med, 6, 485, 10.1016/0891-5849(89)90041-5 Ramassamy, 1992, Prevention by Ginkgo biloba extract (EGb 761) and trolox C of the decrease in synaptosomal dopamine or serotonin uptake following incubation, Biochem Pharmacol, 44, 2395, 10.1016/0006-2952(92)90685-C Nagatsu, 2006, Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells, J Neural Transm Suppl, 71, 53, 10.1007/978-3-211-33328-0_7 Wu, 1999, Involvement of monoamine oxidase inhibition in neuroprotective and restorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C-57 mice, Life Sci, 65, 157, 10.1016/S0024-3205(99)00232-5 Rojas, 2004, EGb 761 pretreatment reduces monoamine oxidase activity in mouse corpus striatum during 1-methyl-4-phenylpyridinium neurotoxicity, Neurochem Res, 29, 1417, 10.1023/B:NERE.0000026406.64547.93 Ramassamy, 1990, Prevention by a Ginkgo biloba extract (EGB 761) of the dopaminergic neurotoxicity of MPTP, J Pharm Pharmacol, 42, 785, 10.1111/j.2042-7158.1990.tb07021.x Melega, 1999, L-amphetamine pharmacokinetics and pharmacodynamics for assessment of in vivo deprenyl-derived L-amphetamine, J Pharmacol Exp Ther, 288, 752 Mattson, 1998, Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity, Trends Neurosci, 21, 53, 10.1016/S0166-2236(97)01188-0 Rimbach, 2001, Induction of glutathione synthesis in human keratinocytes by Ginkgo biloba extract (EGb761), Biofactors, 15, 39, 10.1002/biof.5520150104 Sasaki, 2002, Effects of extract of Ginkgo biloba leaves and its constituents on carcinogen-metabolizing enzyme activities and glutathione levels in mouse liver, Life Sci, 70, 1657, 10.1016/S0024-3205(01)01557-0 Lacour, 1991, Plasticity mechanisms in vestibular compensation in the cat are improved by an extract of Ginkgo biloba (EGb 761), Pharmacol Biochem Behav, 40, 367, 10.1016/0091-3057(91)90568-M Schwarting, 1996, The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments, Prog Neurobiol, 50, 275, 10.1016/S0301-0082(96)00040-8 Gohil, 2002, Global gene expression analysis identifies cell and tissue specific actions of Ginkgo biloba extract, EGb 761, Cell Mol Biol, 48, 625 Cao, 2003, Experimental study on inhibition of neuronal toxical effect of levodopa by ginkgo biloba extract on Parkinson disease in rats, J Huazhong Univ Sci Technol Med Sci, 23, 151, 10.1007/BF02859941